This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Merck Patent Gmbh, Ryvu Therapeutics S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,022 
1 out of 7 Years Active: 2026
Title: Daniel Kuhn - Innovator in Pharmaceutical Research
Introduction: Daniel Kuhn is an inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for the treatment of various medical conditions. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.
Latest Patent Applications: Daniel Kuhn has submitted several patent applications, including "Substituted Heterocycles as HSET Inhibitors." This invention relates to substituted heterocycles of the general formula I, which are used for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans. Another application is for "Tetrazole Derivatives," which are useful for the prevention and/or treatment of several medical conditions, including hyperproliferative disorders and diseases.
Conclusion: Daniel Kuhn's innovative work in pharmaceutical research highlights his commitment to advancing medical science. His latest patent applications reflect his dedication to finding new solutions for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile